🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis

RecruitingEARLY Phase 1Ages 18 Years - 75 YearsAllThe First Affiliated Hospital with Nanjing Medica…
NCT04592640 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Treatment for Calciphylaxis Patients with Human Amniotic-derived Mesenchymal Stem Cells

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. 18-75 years old. 2. Clinical diagnosis of calciphylaxis, including patients with chronic kidney disease who did not or had regular dialysis (hemodialysis or peritoneal dialysis). 3. All subjects signed informed consent. Exclusion criteria: 1. Patients who refuse to sign informed consent. 2. Patients with malignant tumors or severe psychiatric disorders, or an expected survival time of less than 6 months. 3. Pregnant or lactating women of childbearing age. 4. Participation in another clinical trial with an experimental drug within 90 days prior the inclusion.
💊

What it tests

  • Human amniotic-derived mesenchymal stem cells
📍

Where

1 site
The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital
Nanjing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy